Lactogangliotetraosylceramide
| Code | Size | Price |
|---|
| TAR-T25600-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Lactogangliotetraosylceramide is a leukemia-associated antigen possessing a novel branching structure.
CAS:
107221-01-2
Formula:
C70H129N3O23
Molecular Weight:
1380.8
Purity:
0.98
SMILES:
CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H](CO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3NC(C)=O)[C@@H](O[C@H]3O[C@@H](CO)[C@@H](O)[C@@H](O)[C@H]3NC(C)=O)[C@H]2O)[C@H](O)[C@@H]1O)[C@@H](O)C=CCCCCCCCCCCCCC
References
1. Shigeta K, Ito Y, Ogawa T, Kirihata Y, Hakomori S, Kannagi R. Monoclonal antibodies directed to chemically synthesized lactogangliotetraosylceramide, a leukemia-associated antigen having a novel branching structure. J Biol Chem. 1987 Jan 25;262(3):1358-62. PubMed PMID: 3805024.
2. Levery SB, Holmes EH, Harris DD, Hakomori S. 1H NMR studies of a biosynthetic lacto-ganglio hybrid glycosphingolipid: confirmation of structure, interpretation of "anomalous" chemical shifts, and evidence for interresidue amide-amide hydrogen bonding. Biochemistry. 1992 Feb 4;31(4):1069-80. PubMed PMID: 1310419.